How has the management of acute coronary syndrome changed in the Russian Federation during the last 10 years?

Kontsevaya, A. V.; Sabgayda, T.P.; Ivanova, Alla; Leon, David A.; McKee, Martin

doi:10.1016/j.healthpol.2017.09.018

Cited by 17 publications

(19 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, an inadequate government health expenditure in CIS countries (less than 5% of GDP) is a barrier to clinical prevention (e.g., hypertension control), neither it affords the protection against catastrophic expenditures in case of acute CVD events. In additions, several of the CEE/CIS countries contain large rural areas where the life conditions and the access to contemporary treatments and technologies can significantly differ from that in metropolitan areas [48].…”

Section: Challenges and Opportunities For CV Health Promotion In Cee/cismentioning

confidence: 99%

Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion

Movsisyan

Vinciguerra

Medina‐Inojosa

et al. 2020

Annals of Global Health

View full text Add to dashboard Cite

Introduction: Epidemiologic Background and Trajectory Cardiovascular diseases (CVD) remain the leading cause of death in Europe accounting for 45% of all deaths. More than 4 million Europeans die every year from CVD, primarily from coronary heart disease (CHD) and stroke. Many more are hospitalized and many develop long term disability and require lifelong treatment [1]. Besides the human suffering, CVD has major economic implications for Europe. The economic cost CVD imposes to the EU economy is estimated at €210 billion a year, which includes direct health care costs and non-health costs such as productivity losses and the informal care of people with CVD [2]. The region including Central and Eastern Europe (CEE/CIS) has the highest cardiovascular disease mortality in the world [3, 4]. Although CVD mortality in Europe has declined over past decades, the pace of this decline in the European region has significant variability [5]. The World Health Organization's (WHO) European region includes 53 states with diverse sociopolitical and economic backgrounds. In this article we refer to two groups of countries: 1) CEE, including eleven ex-socialist countries (Bulgaria, Croatia,

show abstract

Section: Challenges and Opportunities For CV Health Promotion In Cee/cismentioning

confidence: 99%

Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion

Movsisyan

Vinciguerra

Medina‐Inojosa

et al. 2020

Annals of Global Health

View full text Add to dashboard Cite

show abstract

“…Наше предыдущее исследование [8] показало, что, несмотря на значительные достижения последних лет, объемы реперфузионной терапии пациентов с ИМ в России по-прежнему отстают от ряда индустриально развитых стран. Очевидно, что необходимо учитывать такие сдерживающие факторы, как большая географическая протяженность и низкая плотность населения во многих частях страны.…”

Section: Resultsunclassified

“…Against the background of these investments, some positives changes were recorded, such as an increase in the availability of PCIs and a decrease in in-hospital mortality from MI [8], as well as a decrease in age-standardized death rates from MI from 2006 to 2015 by 13.9% [9].…”

Section: Hospital Stage Of Myocardial Infarction Treatment In Russiamentioning

confidence: 99%

“…На фоне этих инвестиций были зафиксирован ряд позитивных изменений, таких как увеличение доступности ЧКВ и снижение госпитальной летальности от ИМ [8], а также снижение стандартизованных по возрасту показателей смертности от ИМ с 2006 по 2015 гг. на 13,9% [9].…”

Section: Hospital Stage Of Myocardial Infarction Treatment In Russiaunclassified

“…Our previous research [8] has shown how, despite substantial improvements in recent years, rates of reperfusion of patients with MI in Russia still lag those in advanced industrial economies. Obviously, it is necessary to take account of the geographical constraints, given the low population density in many parts of the country.…”

Section: Hospital Stage Of Myocardial Infarction Treatment In Russia mentioning

confidence: 99%

See 2 more Smart Citations

Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research

Kontsevaya

Bates

Goryachkin

et al. 2018

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Aim. To describe the characteristics of the patient with MI who is admitted to a hospital and to characterize the main diagnostic and treatment interventions in clinic. Material and methods. This study is observational and the part of big international project. It includes a representative sample of patients with MI admitted to 16 clinics in 13 regions of Russian Federation (Arkhangelsk region, Belgorod region, Bryansk region, Tver region, Saratov region, Rostov region, Samara region, the Republic of Tatarstan, Perm region, Tyumen region, Khanty-Mansiysk Autonomous district, Kemerovo region, Altai region). Patients were selected at random from among those experiencing a MI that were alive on the next morning after hospitalization. Enrollment took place from June 2015 to August 2016. Results. Of 1,128 patients included in the study, 872 were male (77.3%) and 256 females. 21.4% of patients had a previous MI, 8.3% had undergone PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior to hospitalization, 34.6% were obese and 52.1% had a high cholesterol level. Only 40.0% of patients had no contact with the health care system within 12 months before the MI. Every fourth patient (25.1%) had undergone dispensarisation within 12 months before MI, women significantly often than men (33.5% and 22.6%, p<0.001). Initial revascularization was performed in 73.2% of patients, PCI was the initial revascularization attempt in 49.4% of patients, and PCI with stenting in 46.7%. Conclusion. Patient with a MI in Russian clinics is likely to have had a history of cardiovascular disease, and to have regular contact with the health care system within 12 months before the development of cardiovascular event. We demonstrated the high rates of appropriate MI treatment, without significant gender and age difference (except for thrombolysis), however, there is a reserve for increasing the proportion of patients who are undergoing revascularization.

show abstract

Understanding the role of physicians within the managerial structure of Russian hospitals

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

How has the management of acute coronary syndrome changed in the Russian Federation during the last 10 years?

Cited by 17 publications

References 28 publications

Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion

Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion

Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research

Understanding the role of physicians within the managerial structure of Russian hospitals

Contact Info

Product

Resources

About